6th Nov 2009 14:28
Date: 6 November 2009
Dechra® Pharmaceuticals PLC
(the "Company" or the "Group")
Results of Annual General Meeting ("AGM")
Dechra Pharmaceuticals PLC announces that all resolutions proposed at its AGM held on 6 November 2009 were duly passed on a show of hands.
Copies of the following:
Ordinary resolution relating to the renewal of the authority for the directors to allot new shares;
Special resolution relating to the renewal of the authority for the directors to disapply pre-emption rights;
Special resolution relating to the renewal of the authority for the Company to purchase its own shares;
Special resolution relating to the calling of any general meeting of the Company (other than an AGM) on not less than 14 clear days notice; and
Special resolution relating to the deletion of the current memorandum of Association and adoption of new Articles of Association,
being resolutions (other than resolutions concerning ordinary business) passed by the Company at its AGM on 6 November 2009, will be submitted to the UK Listing Authority and will thereafter be available for publication at the UK Listing Authority's Document Viewing Facility which is situated at :
Financial Services Authority
25 The North Colonnade
Canary Wharf
London E14 5HS
Tel : 020 7066 1000
Details of the proxy voting instructions lodged prior to the AGM are set out below:
|
Resolution (No. as noted on proxy form) |
For |
Against |
Discretionary |
Withheld |
|
Resolution 1: To receive and consider report and accounts |
48,564,546 |
29,100 |
108,998 |
120,000 |
|
Resolution 2: To receive and approve the Directors Remuneration Report |
44,705,769 |
35,807 |
108,998 |
3,972,070 |
|
Resolution 3: To declare a final dividend |
48,593,646 |
0 |
108,998 |
120,000 |
|
Resolution 4: To re-elect Simon Evans |
47,543,459 |
1,049,699 |
108,998 |
120,488 |
|
Resolution 5: To re-elect Malcolm Diamond |
47,152,727 |
1,402,148 |
108,998 |
158,771 |
|
Resolution 6: To re-appoint KPMG Audit plc as Auditors |
47,912,195 |
6,187 |
783,774 |
120,488 |
|
Resolution 7: To authorise the Directors to fix the Auditors Remuneration |
47,911,328 |
4,638 |
783,407 |
123,271 |
|
Resolution 8: To grant authority to allot equity securities |
47,298,926 |
38,138 |
112,331 |
1,373,249 |
|
Resolution 9: To renew authority for pre-emptive allotment of equity securities |
48,582,856 |
5,134 |
112,331 |
122,323 |
|
Resolution 10: To grant authority to the Company to purchase |
48,583,581 |
6,732 |
112,331 |
120,000 |
|
Resolution 11: To call general meetings (other than an AGM) on not less than 14 clear days notice |
48,079,695 |
510,260 |
112,689 |
120,000 |
|
Resolution 12: To delete the existing memorandum of Association and adopt New Articles of Association |
47,681,002 |
538,040 |
112,456 |
491,146 |
|
Enquiries: |
||
|
Zoe Goulding, Company Secretary |
Dechra Pharmaceuticals PLC |
Tel: +44 (0) 1782 771100 |
Dechra and the Dechra 'D' logo are registered Trade Marks of Dechra Pharmaceuticals PLC
Related Shares:
DPH.L